JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fay, A
Right arrow Articles by Abinun, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fay, A
Right arrow Articles by Abinun, M
Journal of Clinical Pathology 2002;55:266-270
© 2002 Journal of Clinical Pathology


REVIEW

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)

A Fay1, M Abinun2

1 Department of Immunology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne NE1 4LP, UK
2 Department of Paediatrics, Newcastle upon Tyne Hospitals NHS Trust

Correspondence to:
Dr A Fay, Department of Immunology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK;
Fiona.Campbell{at}nuth.northy.nhs.uk
ABSTRACT
Hereditary angio-oedema is characterised by recurrent swellings in any part of the body and also by recurrent attacks of severe abdominal pain. The disease is inherited in an autosomal dominant manner but up to 25% of cases can occur as a spontaneous mutation. Attacks of swelling can be precipitated by trauma, certain drugs, and emotional stress. Treatment usually involves a combination of prophylaxis, using androgens or antifibrolytic drugs, and replacement with C'1 esterase inhibitor concentrate for acute attacks and before surgery or other traumatic procedures.


Keywords: hereditary angio-oedema; C`1 inhibitor protein; complement activation; treatment

Abbreviations: FFP, fesh frozen plasma; HAE, hereditary angio-oedema; HCV, hepatitis C virus; HGV, hepatitis G virus




This article has been cited by other articles:


Home page
Emerg. Med. J.Home page
M Langran and C Laird
8 Management of allergy, rashes, and itching
Emerg. Med. J., November 1, 2004; 21(6): 728 - 741.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.